An experimental Ebola vaccine appearssafe and triggered signs of immune protection in the first 20 volunteers to test it, U.S. researchers reported Wednesday. 'Seems to work': The first participant enrolled in an experimental Ebola vaccine at the National Institute of Health (NIH) Clinical Center in Bethesda, Md. This week,